Repare Therapeutics receives $40 million Roche payment
Clinical-stage precision oncology company, Repare Therapeutics Inc., has received a $40 million milestone payment from Roche after dosing the first patient in a clinical trial.
Lloyd Segal Lung Morpheus Clinical Development Markets Amp Regulations Pis Active Pharmaceutical Ingredients Repare Therapeutics
Source: outsourcing-pharma.com